외상으로 인한 진행성 출혈이 동반된 와파린 복용환자에서의 새로운 경구 항응고제의 적용
The traditional drug for anticoagulation in those with a high risk of thrombosis is a vitamin K antagonist, such as warfarin. On the other hand, this drug has several limitations and hemorrhagic complications. Recently, novel or non-vitamin K-dependent antagonist oral anticoagulants (NOACs) have bee...
Saved in:
Published in | Journal of acute care surgery pp. 33 - 37 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | Korean |
Published |
대한외상중환자외과학회
01.04.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 2288-5862 2288-9582 |
DOI | 10.17479/jacs.2018.8.1.33 |
Cover
Summary: | The traditional drug for anticoagulation in those with a high risk of thrombosis is a vitamin K antagonist, such as warfarin. On the other hand, this drug has several limitations and hemorrhagic complications. Recently, novel or non-vitamin K-dependent antagonist oral anticoagulants (NOACs) have been developed to solve these problems. This paper presents a case of adaptation of NOAC for a warfarin anticoagulated patient with traumatic ongoing hemorrhages with a discussion of the clinical implications of NOAC. (J Acute Care Surg 2018;8:33-37) KCI Citation Count: 0 |
---|---|
ISSN: | 2288-5862 2288-9582 |
DOI: | 10.17479/jacs.2018.8.1.33 |